References
- Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National Heart, Lung and Blood Institute, Bethesda, MD 1998, The Evidence Report
- World Health Organization. Obesity: Preventing and Managing the Global Epidemic. WHO, Geneva 1998, Report of a WHO Consultation on Obesity
- Bray G A. Contemporary Diagnosis and Management of Obesity. Handbooks in Healthcare, Newtown, PA 1998
- Sjöström C D, Lissner L, Sjöström L. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study. Swedish Obese Subjects. Obes Res 1997; 5: 519–30
- Williamson D F, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40–64 years. Am J Epidemiol 1995; 141: 1128–41
- Institute of Medicine. Weighing the Options: Criteria for Evaluating Weight-Management Programs, P R Thomas. National Academy Press, Washington, DC 1995
- Bray G A, Bouchard C, James W PT. Handbook of Obesity. Dekker, New York 1997
- Connolly H E, Crary J L, McGoon M D, Hensrud D D, Edwards D S, Edwards W D, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337: 581–8
- Bray G A, Ryan D H, Gordon D, Heidingsfelder Cerise F, Wilson K. A double-blind randomized placebo-controlled trial of siutramine. Obes Res 1996; 4: 263–70
- Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar H PF, et al. Randomized, placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicenter Orlistat Study Group. Lancet 1998; 352: 167–72